X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
AJANTA PHARMA Fact Sheet, AJANTA PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Fact Sheet   (AJPH)

Here is the latest financial fact sheet of AJANTA PHARMA. For more details, see the AJANTA PHARMA quarterly results and AJANTA PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

AJANTA PHARMA Price History

Price Rs 1,119.7
Mkt Cap Rs m 98,473
Vol '000 58.1
P/E X 20.8
P/CF X 18.6
EPS (TTM) Rs 53.8
% ch % 3.4
No. of shares m 87.95
% ch week % 3.6
% ch 1-mth % 8.9
% ch 12-mth % -8.4
52 week H/L Rs 1,592.0/897.6
(As on Nov 16, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

AJANTA PHARMA Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
AJANTA PHARMA EQUITY SHARE DATA
High Rs1,1777791,7202,0981,818 
Low Rs6252991,1031,3511,106 
Sales per share (Unadj.) Rs340.8166.1195.3223.4239.5 
Earnings per share (Unadj.) Rs66.034.946.857.152.8 
Diluted earnings per shareRs26.635.247.357.653.3 
Cash flow per share (Unadj.) Rs78.340.851.864.059.5 
Dividends per share (Unadj.) Rs10.006.008.0013.000 
Adj. dividends per shareRs4.036.058.0713.120.00 
Dividend yield (eoy) %1.11.10.60.80 
Book value per share (Unadj.) Rs167.394.8134.2176.6230.0 
Adj. book value per shareRs67.595.6135.4178.2232.1 
Shares outstanding (eoy) m35.4688.7188.7788.7788.77 
Bonus/Rights/Conversions  B1:2,ESOSFV2--- 
Price / Sales ratio x2.63.27.27.76.1 
Avg P/E ratio x13.715.430.130.227.7 
P/CF ratio (eoy) x11.513.227.226.924.6 
Price / Book Value ratio x5.45.710.59.86.4 
Dividend payout %15.217.217.122.80 
Avg Mkt Cap Rs m31,95147,797125,299153,062129,782 
No. of employees `000NANANANA6.8 
Total wages/salary Rs m1,5702,0062,5662,9543,765 
Avg. sales/employee Rs ThNMNMNMNM3,128.4 
Avg. wages/employee Rs ThNMNMNMNM554.0 
Avg. net profit/employee Rs ThNMNMNMNM689.7 
AJANTA PHARMA INCOME DATA
Net Sales Rs m12,08314,73617,34019,83321,258 
Other income Rs m137168212239242 
Total revenues Rs m12,22114,90417,55120,07121,499 
Gross profit Rs m3,6885,0525,8716,8696,584 
Depreciation Rs m439516444612596 
Interest Rs m875949144 
Profit before tax Rs m3,2994,6455,5896,4826,226 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m0-85000 
Tax Rs m9601,4621,4331,4131,539 
Profit after tax Rs m2,3393,0994,1565,0684,686 
Gross profit margin %30.534.333.934.631.0 
Effective tax rate %29.131.525.621.824.7 
Net profit margin %19.421.024.025.622.0 
AJANTA PHARMA BALANCE SHEET DATA
Current assets Rs m5,2016,3347,6398,50612,236 
Current liabilities Rs m2,7542,4962,7152,4673,461 
Net working cap to sales %20.226.028.430.541.3 
Current ratio x1.92.52.83.43.5 
Inventory Days Days4739433960 
Debtors Days Days6164785984 
Net fixed assets Rs m3,7294,5836,9149,28411,140 
Share capital Rs m177177177177177 
"Free" reserves Rs m5,6508,18611,73215,50020,237 
Net worth Rs m5,9338,41111,90915,67720,414 
Long term debt Rs m5233331491010 
Total assets Rs m9,49411,43414,88018,47724,486 
Interest coverage x38.879.5115.3477.61,519.4 
Debt to equity ratio x0.10000 
Sales to assets ratio x1.31.31.21.10.9 
Return on assets %25.627.628.327.519.2 
Return on equity %39.436.834.932.323.0 
Return on capital %52.452.846.841.430.5 
Exports to sales %54.754.754.900 
Imports to sales %5.04.46.000 
Exports (fob) Rs m6,6068,0629,52700 
Imports (cif) Rs m6026531,03800 
Fx inflow Rs m6,8968,49410,42211,47711,667 
Fx outflow Rs m1,1681,2471,6782,2061,616 
Net fx Rs m5,7287,2478,7449,27110,052 
AJANTA PHARMA CASH FLOW
From Operations Rs m 2,124 2,794 3,261 6,093 2,854 
From Investments Rs m -1,878 -1,584 -2,091 -3,831 -2,604 
From Financial Activity Rs m -201 -1,052 -1,173 -2,018 -2 
Net Cashflow Rs m 45 159 -3 244 248 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 73.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 1.6%
FIIs 7.6%
ADR/GDR 0.0%
Free float 17.0%
Shareholders 20,968
Pledged promoter(s) holding 4.4%
 

Company Information

REGD OFF Ajanta House, Charkop, Kandivli (W), Mumbai - 400 067
E-MAIL deodatta.pandit@ajantapharma.com WEB www.ajantapharma.com
TELEPHONE (022) 66061000 FAX (022) 6606 1200
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Compd., LBS Marg, Mumbai-78
AUDITOR Kapoor & Parekh Assoc.
CHM: Mannalal B. Agrawal COMP SEC: Gaurang Shah YEAR OF INC: 1979 BSE CODE: 532331 FV (Rs): 5 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   ASTRAZENECA PHARMA  ALEMBIC LTD  SUN PHARMA  DISHMAN PHARMA  ALEMBIC PHARMA  

Compare AJANTA PHARMA With:   ASTRAZENECA PHARMA  ALEMBIC LTD  SUN PHARMA  DISHMAN PHARMA  ALEMBIC PHARMA  

Compare AJANTA PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Week Strong, Pharma Stocks Show Uptick(Pre-Open)

On Friday, share markets in India opened on a positive note and ended the day in green after a volatile day of trading.

Views on news

AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 4.9% YoY). Sales on the other hand came in at Rs 5 bn (up 0.7% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 11.6% (Quarterly Result Update)

Aug 1, 2018 | Updated on Aug 1, 2018

For the quarter ended June 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 11.6% YoY). Sales on the other hand came in at Rs 5 bn (up 8.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AJANTA PHARMA

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS